167 related articles for article (PubMed ID: 35804431)
1. Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study.
Cheng C; Xu W; Wang Y; Zhang T; Yang L; Zhou W; Hu D; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2022 Jul; 17(1):257. PubMed ID: 35804431
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis.
Sakurai T; Arai T; Hirose M; Kojima K; Sakamoto T; Matsuda Y; Sugimoto C; Yoon HE; Inoue Y
Orphanet J Rare Dis; 2021 Nov; 16(1):466. PubMed ID: 34732225
[TBL] [Abstract][Full Text] [Related]
3. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
Takia L; Jat KR; Mandal A; Kabra SK
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series.
Zhou L; Ouyang R; Luo H; Ren S; Chen P; Peng Y; Liu T; Liu G
Orphanet J Rare Dis; 2018 Sep; 13(1):168. PubMed ID: 30241551
[TBL] [Abstract][Full Text] [Related]
5. Air travel and incidence of pneumothorax in lymphangioleiomyomatosis.
Gonano C; Pasquier J; Daccord C; Johnson SR; Harari S; Leclerc V; Falconer L; Miano E; Cordier JF; Cottin V; Lazor R
Orphanet J Rare Dis; 2018 Dec; 13(1):222. PubMed ID: 30545392
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM).
Shen L; Xu W; Gao J; Wang J; Huang J; Wang Y; He Y; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2021 Mar; 16(1):133. PubMed ID: 33731151
[TBL] [Abstract][Full Text] [Related]
7. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.
Almoosa KF; Ryu JH; Mendez J; Huggins JT; Young LR; Sullivan EJ; Maurer J; McCormack FX; Sahn SA
Chest; 2006 May; 129(5):1274-81. PubMed ID: 16685019
[TBL] [Abstract][Full Text] [Related]
8. Probability of sporadic lymphangioleiomyomatosis in women presenting with spontaneous pneumothorax.
Suter A; Müller ME; Daccord C; Taffé P; Lazor R
Orphanet J Rare Dis; 2023 Jul; 18(1):180. PubMed ID: 37415209
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
Wang Q; Luo M; Xiang B; Chen S; Ji Y
Respir Res; 2020 Feb; 21(1):55. PubMed ID: 32059669
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary lymphangioleiomyomatosis: report of one case].
Silva O R; Puelma C F; Retamal P V; Rojas Sm P; Cruzat C C; Reyes G C
Rev Med Chil; 2009 Nov; 137(11):1474-7. PubMed ID: 20098807
[TBL] [Abstract][Full Text] [Related]
11. Emerging clinical picture of lymphangioleiomyomatosis.
Cohen MM; Pollock-BarZiv S; Johnson SR
Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
[TBL] [Abstract][Full Text] [Related]
12. Successful pregnancy complicated by persistent pneumothorax in a patient with lymphangioleiomyomatosis (LAM) on sirolimus.
Faehling M; Frohnmayer S; Leschke M; Trinajstic-Schulz B; Weber J; Liewald F
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):153-5. PubMed ID: 22117507
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of spontaneous pneumothorax in patients with pulmonary lymphangioleiomyomatosis].
Sato T; Seyama K; Kodama Y; Tamaki Y; Zenba M; Ohnishi M; Dambara T; Kira S; Fukuchi Y
Nihon Kokyuki Gakkai Zasshi; 2001 Sep; 39(9):656-63. PubMed ID: 11729684
[TBL] [Abstract][Full Text] [Related]
14. Lymphangioleiomyomatosis treatment with sirolimus.
Casanova A; María Girón R; Acosta O; Barrón M; Valenzuela C; Ancochea J
Arch Bronconeumol; 2011 Sep; 47(9):470-2. PubMed ID: 21440356
[TBL] [Abstract][Full Text] [Related]
15. Lymphangioleiomyomatosis: a clinical update.
McCormack FX
Chest; 2008 Feb; 133(2):507-16. PubMed ID: 18252917
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.
Cai X; Pacheco-Rodriguez G; Haughey M; Samsel L; Xu S; Wu HP; McCoy JP; Stylianou M; Darling TN; Moss J
Chest; 2014 Jan; 145(1):108-112. PubMed ID: 24051985
[TBL] [Abstract][Full Text] [Related]
17. Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.
Gopalakrishnan V; Yao J; Steagall WK; Avila NA; Taveira-DaSilva AM; Stylianou M; Chen MY; Moss J
Chest; 2019 May; 155(5):962-971. PubMed ID: 30660784
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus Suppresses Phosphorylation of Cofilin and Reduces Interstitial Septal Thickness in Sporadic Lymphangioleiomyomatosis.
Huang YL; Chen PR; Lai YJ; Hsu HH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445268
[TBL] [Abstract][Full Text] [Related]
20. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
